Hoffman G S, Ahmed A E
Rheumatic/Immunologic Diseases A50, INSSYS, Cleveland Clinic Foundation, OH 44195, USA.
Int J Cardiol. 1998 Oct 1;66 Suppl 1:S191-4; discussion S195. doi: 10.1016/s0167-5273(98)00181-8.
Twenty-nine patients with clinically defined Takayasu arteritis and 26 healthy control volunteers were recruited by INSSYS investigators from their clinical practices. Patients with Takayasu arteritis were divided into those with clear-cut clinically active or inactive disease based on Birmingham Vasculitis Activity Scores. Multiple serological tests were performed including ESR, C-reactive protein, tissue factor, von Willebrand factor, thrombomodulin, tissue plasminogen activator, ICAM-1, VCAM-1, E-selectin and PECAM-1. No test was reliably able to distinguish between healthy volunteers and patients with active Takayasu arteritis. At present there is no known serological test which can consistently supplant vascular histopathology in determining the activity of Takayasu arteritis.
INSSYS研究人员从其临床实践中招募了29名临床确诊的大动脉炎患者和26名健康对照志愿者。根据伯明翰血管炎活动评分,大动脉炎患者被分为临床活动期或非活动期明确的患者。进行了多项血清学检测,包括血沉、C反应蛋白、组织因子、血管性血友病因子、血栓调节蛋白、组织型纤溶酶原激活剂、细胞间黏附分子-1、血管细胞黏附分子-1、E选择素和血小板内皮细胞黏附分子-1。没有一种检测能够可靠地区分健康志愿者和活动期大动脉炎患者。目前,尚无已知的血清学检测能够在确定大动脉炎活动度方面始终如一地取代血管组织病理学检查。